Depression and the menopause: why antidepressants are not enough?

Area of Science:

• Reproductive Endocrinology
• Neuropsychiatry
• Gerontology

Background:

• Women experience higher rates of mood disorders, particularly depression, from puberty onwards, with increased vulnerability during the menopausal transition.
• Estrogen fluctuations and loss during perimenopause are debated as specific etiological factors for depression.
• Gender differences in hormone levels and secretion patterns contribute to women's susceptibility to mood disorders.

Purpose of the Study:

• To review the interplay between menopausal hormonal changes, mood disorders, and aging.
• To evaluate therapeutic options for perimenopausal mood disorders, including hormonal therapy (HT), antidepressants, and their combined use.

Main Methods:

• Review of existing literature on menopause, mood disorders, and therapeutic interventions.
• Analysis of predictive factors for depression during menopause.
• Evaluation of treatment efficacy for menopausal depression.

Main Results:

• Menopausal depression has a multifactorial origin, with factors like prior depressive episodes, menopausal symptoms (hot flashes, insomnia), and socioeconomic status playing a role.
• Postmenopausal depression is often more severe and less responsive to antidepressants alone compared to premenopausal depression.
• Hormone therapy (HT) combined with antidepressants shows superior outcomes for menopausal depression.

Conclusions:

• Evidence suggests a significant relationship between menopause and depression, necessitating a nuanced understanding.
• Combined treatment with antidepressants and HT appears most promising for efficacy, rapid improvement, and sustained remission in menopausal depression.